Sign In
BSX.US
id: 913

Boston Scientific (BSX) $38.5M Shareholder Settlement

D. Massachusetts
Court
1:20-cv-12225
Case number
16 Sept 2020
Class period Start
16 Nov 2020
Class period End
28 May 2024
Claim deadline
Boston Scientific (BSX) settles $38.5 million with investors to end claims over the promoted heart valve product, later withdrawn from the market.
Case Status
Accepting Claims
Alleged Offence
Misleading Statements
Failure to Disclose
Omissions
Suspected Party
Directors
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.43
Filing date
04 December 2020
Plaintiffs
Union Asset Management Holding AG
Attorneys
Bernstein Litowitz Berger & Grossmann LLP
Defendants
Michael F. Mahoney, Daniel J. Brennan, Shawn McCarthy, Ian Meredith, Joseph M. Fitzgerald, Kevin Ballinger, Susan Vissers Lisa
Judge
Hon. Douglas P. Woodlock
Administrator
JND Legal Administration
Settlement agreement date
2023-12-15
Court hearing date
23 April 2024
Exclusion deadline
02 April 2024
Objection deadline
02 April 2024
Hearing deadline
02 April 2024
Trades matching type
FIFO
+$38,500,000
Cash Settlement Amount

Frequently Asked Questions

Boston Scientific Corp

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Card...

    Ticker
    BSX.US
    ISIN
    US1011371077
    CIK
    885725
    Sector
    Healthcare
    Industry
    Medical Devices
    Country
    USA
    Address
    300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234